Vitrolife AB (publ)

Stockholm Stock Exchange:VITR.ST

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🧬 Biotechnology

🔬 Clinical Trials

💻 Telehealth

Location

Sweden

Market Cap

USD 2.01 B

Share Price

USD 14.82

Avg Daily Volume

193,487

Change (1 day)

2.00%

Change (1 year)

-8.60%

Change (YTD)

-23.69%

Vitrolife AB (publ) Inventory for the year ending December 31, 2024: USD 37.98 M

Vitrolife AB (publ) Inventory is USD 37.98 M for the year ending December 31, 2024, a -6.83% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Vitrolife AB (publ) Inventory for the year ending December 31, 2023 was USD 40.76 M, a 5.39% change year over year.
Vitrolife AB (publ) Inventory for the year ending December 31, 2022 was USD 38.68 M, a 12.27% change year over year.
Vitrolife AB (publ) Inventory for the year ending December 31, 2021 was USD 34.45 M, a 39.31% change year over year.
Vitrolife AB (publ) Inventory for the year ending December 31, 2020 was USD 24.73 M, a 11.30% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Inventory	Current Assets	Property, Plant, Equipment (Net)	Total Assets

Stockholm Stock Exchange: VITR.ST

Vitrolife AB (publ)

CEO	Ms. Bronwyn Brophy O´Connor
IPO Date	June 28, 2001
Location	Sweden
Headquarters	Gustaf Werners gata 2
Employees	1,150
Sector	🏥 Health Care
Industries Medical Instruments 🧬 Biotechnology 🔬 Clinical Trials 💻 Telehealth

Description

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.